Longitudinal molecular trajectories of diffuse glioma in adults. Barthel, F. P., Johnson, K. C., Varn, F. S., Moskalik, A. D., Tanner, G., Kocakavuk, E., Anderson, K. J., Abiola, O., Aldape, K., Alfaro, K. D., Alpar, D., Amin, S. B., Ashley, D. M., Bandopadhayay, P., Barnholtz-Sloan, J. S., Beroukhim, R., Bock, C., Brastianos, P. K., Brat, D. J., Brodbelt, A. R., Bruns, A. F., Bulsara, K. R., Chakrabarty, A., Chakravarti, A., Chuang, J. H., Claus, E. B., Cochran, E. J., Connelly, J., Costello, J. F., Finocchiaro, G., Fletcher, M. N., French, P. J., Gan, H. K., Gilbert, M. R., Gould, P. V., Grimmer, M. R., Iavarone, A., Ismail, A., Jenkinson, M. D., Khasraw, M., Kim, H., Kouwenhoven, M. C. M., LaViolette, P. S., Li, M., Lichter, P., Ligon, K. L., Lowman, A. K., Malta, T. M., Mazor, T., McDonald, K. L., Molinaro, A. M., Nam, D. H., Nayyar, N., Ng, H. K., Ngan, C. Y., Niclou, S. P., Niers, J. M., Noushmehr, H., Noorbakhsh, J., Ormond, D. R., Park, C. K., Poisson, L. M., Rabadan, R., Radlwimmer, B., Rao, G., Reifenberger, G., Sa, J. K., Schuster, M., Shaw, B. L., Short, S. C., Smitt, P. A. S., Sloan, A. E., Smits, M., Suzuki, H., Tabatabai, G., Van Meir, E. G., Watts, C., Weller, M., Wesseling, P., Westerman, B. A., Widhalm, G., Woehrer, A., Yung, W. K. A., Zadeh, G., Huse, J. T., De Groot, J. F., Stead, L. F., & Verhaak, R. G. W. Nature, 576(7785):112-120, 2019. 1476-4687 Barthel, Floris P Johnson, Kevin C Varn, Frederick S Moskalik, Anzhela D Tanner, Georgette Kocakavuk, Emre Anderson, Kevin J Abiola, Olajide Aldape, Kenneth Alfaro, Kristin D Alpar, Donat Amin, Samirkumar B Ashley, David M Bandopadhayay, Pratiti Barnholtz-Sloan, Jill S Beroukhim, Rameen Bock, Christoph Brastianos, Priscilla K Brat, Daniel J Brodbelt, Andrew R Bruns, Alexander F Bulsara, Ketan R Chakrabarty, Aruna Chakravarti, Arnab Chuang, Jeffrey H Claus, Elizabeth B Cochran, Elizabeth J Connelly, Jennifer Costello, Joseph F Finocchiaro, Gaetano Fletcher, Michael N French, Pim J Gan, Hui K Gilbert, Mark R Gould, Peter V Grimmer, Matthew R Iavarone, Antonio Ismail, Azzam Jenkinson, Michael D Khasraw, Mustafa Kim, Hoon Kouwenhoven, Mathilde C M LaViolette, Peter S Li, Meihong Lichter, Peter Ligon, Keith L Lowman, Allison K Malta, Tathiane M Mazor, Tali McDonald, Kerrie L Molinaro, Annette M Nam, Do-Hyun Nayyar, Naema Ng, Ho Keung Ngan, Chew Yee Niclou, Simone P Niers, Johanna M Noushmehr, Houtan Noorbakhsh, Javad Ormond, D Ryan Park, Chul-Kee Poisson, Laila M Rabadan, Raul Radlwimmer, Bernhard Rao, Ganesh Reifenberger, Guido Sa, Jason K Schuster, Michael Shaw, Brian L Short, Susan C Smitt, Peter A Sillevis Sloan, Andrew E Smits, Marion Suzuki, Hiromichi Tabatabai, Ghazaleh Van Meir, Erwin G Watts, Colin Weller, Michael Wesseling, Pieter Westerman, Bart A Widhalm, Georg Woehrer, Adelheid Yung, W K Alfred Zadeh, Gelareh Huse, Jason T De Groot, John F Stead, Lucy F Verhaak, Roel G W GLASS Consortium R01 CA188228/CA/NCI NIH HHS/United States P30 CA016672/CA/NCI NIH HHS/United States R01 CA190121/CA/NCI NIH HHS/United States UL1 TR001863/TR/NCATS NIH HHS/United States CA170278/CA/NCI NIH HHS/United States P30 CA034196/CA/NCI NIH HHS/United States K99 CA226387/CA/NCI NIH HHS/United States U54 CA193313/CA/NCI NIH HHS/United States R01 CA215489/CA/NCI NIH HHS/United States R00 CA226387/CA/NCI NIH HHS/United States R01 CA219943/CA/NCI NIH HHS/United States R01 CA108888/CA/NCI NIH HHS/United States R01 NS094615/NS/NINDS NIH HHS/United States R21 NS114873/NS/NINDS NIH HHS/United States R01 CA179044/CA/NCI NIH HHS/United States T32 GM008568/GM/NIGMS NIH HHS/United States R01 CA230031/CA/NCI NIH HHS/United States R01 CA218144/CA/NCI NIH HHS/United States R01 CA222146/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't England 2019/11/22 Nature. 2019 Dec;576(7785):112-120. doi: 10.1038/s41586-019-1775-1. Epub 2019 Nov 20.
doi  abstract   bibtex   1 download  
The evolutionary processes that drive universal therapeutic resistance in adult patients with diffuse glioma remain unclear(1,2). Here we analysed temporally separated DNA-sequencing data and matched clinical annotation from 222 adult patients with glioma. By analysing mutations and copy numbers across the three major subtypes of diffuse glioma, we found that driver genes detected at the initial stage of disease were retained at recurrence, whereas there was little evidence of recurrence-specific gene alterations. Treatment with alkylating agents resulted in a hypermutator phenotype at different rates across the glioma subtypes, and hypermutation was not associated with differences in overall survival. Acquired aneuploidy was frequently detected in recurrent gliomas and was characterized by IDH mutation but without co-deletion of chromosome arms 1p/19q, and further converged with acquired alterations in the cell cycle and poor outcomes. The clonal architecture of each tumour remained similar over time, but the presence of subclonal selection was associated with decreased survival. Finally, there were no differences in the levels of immunoediting between initial and recurrent gliomas. Collectively, our results suggest that the strongest selective pressures occur during early glioma development and that current therapies shape this evolution in a largely stochastic manner.
@article{RN6082,
   author = {Barthel, F. P. and Johnson, K. C. and Varn, F. S. and Moskalik, A. D. and Tanner, G. and Kocakavuk, E. and Anderson, K. J. and Abiola, O. and Aldape, K. and Alfaro, K. D. and Alpar, D. and Amin, S. B. and Ashley, D. M. and Bandopadhayay, P. and Barnholtz-Sloan, J. S. and Beroukhim, R. and Bock, C. and Brastianos, P. K. and Brat, D. J. and Brodbelt, A. R. and Bruns, A. F. and Bulsara, K. R. and Chakrabarty, A. and Chakravarti, A. and Chuang, J. H. and Claus, E. B. and Cochran, E. J. and Connelly, J. and Costello, J. F. and Finocchiaro, G. and Fletcher, M. N. and French, P. J. and Gan, H. K. and Gilbert, M. R. and Gould, P. V. and Grimmer, M. R. and Iavarone, A. and Ismail, A. and Jenkinson, M. D. and Khasraw, M. and Kim, H. and Kouwenhoven, M. C. M. and LaViolette, P. S. and Li, M. and Lichter, P. and Ligon, K. L. and Lowman, A. K. and Malta, T. M. and Mazor, T. and McDonald, K. L. and Molinaro, A. M. and Nam, D. H. and Nayyar, N. and Ng, H. K. and Ngan, C. Y. and Niclou, S. P. and Niers, J. M. and Noushmehr, H. and Noorbakhsh, J. and Ormond, D. R. and Park, C. K. and Poisson, L. M. and Rabadan, R. and Radlwimmer, B. and Rao, G. and Reifenberger, G. and Sa, J. K. and Schuster, M. and Shaw, B. L. and Short, S. C. and Smitt, P. A. S. and Sloan, A. E. and Smits, M. and Suzuki, H. and Tabatabai, G. and Van Meir, E. G. and Watts, C. and Weller, M. and Wesseling, P. and Westerman, B. A. and Widhalm, G. and Woehrer, A. and Yung, W. K. A. and Zadeh, G. and Huse, J. T. and De Groot, J. F. and Stead, L. F. and Verhaak, R. G. W.},
   title = {Longitudinal molecular trajectories of diffuse glioma in adults},
   journal = {Nature},
   volume = {576},
   number = {7785},
   pages = {112-120},
   note = {1476-4687
Barthel, Floris P
Johnson, Kevin C
Varn, Frederick S
Moskalik, Anzhela D
Tanner, Georgette
Kocakavuk, Emre
Anderson, Kevin J
Abiola, Olajide
Aldape, Kenneth
Alfaro, Kristin D
Alpar, Donat
Amin, Samirkumar B
Ashley, David M
Bandopadhayay, Pratiti
Barnholtz-Sloan, Jill S
Beroukhim, Rameen
Bock, Christoph
Brastianos, Priscilla K
Brat, Daniel J
Brodbelt, Andrew R
Bruns, Alexander F
Bulsara, Ketan R
Chakrabarty, Aruna
Chakravarti, Arnab
Chuang, Jeffrey H
Claus, Elizabeth B
Cochran, Elizabeth J
Connelly, Jennifer
Costello, Joseph F
Finocchiaro, Gaetano
Fletcher, Michael N
French, Pim J
Gan, Hui K
Gilbert, Mark R
Gould, Peter V
Grimmer, Matthew R
Iavarone, Antonio
Ismail, Azzam
Jenkinson, Michael D
Khasraw, Mustafa
Kim, Hoon
Kouwenhoven, Mathilde C M
LaViolette, Peter S
Li, Meihong
Lichter, Peter
Ligon, Keith L
Lowman, Allison K
Malta, Tathiane M
Mazor, Tali
McDonald, Kerrie L
Molinaro, Annette M
Nam, Do-Hyun
Nayyar, Naema
Ng, Ho Keung
Ngan, Chew Yee
Niclou, Simone P
Niers, Johanna M
Noushmehr, Houtan
Noorbakhsh, Javad
Ormond, D Ryan
Park, Chul-Kee
Poisson, Laila M
Rabadan, Raul
Radlwimmer, Bernhard
Rao, Ganesh
Reifenberger, Guido
Sa, Jason K
Schuster, Michael
Shaw, Brian L
Short, Susan C
Smitt, Peter A Sillevis
Sloan, Andrew E
Smits, Marion
Suzuki, Hiromichi
Tabatabai, Ghazaleh
Van Meir, Erwin G
Watts, Colin
Weller, Michael
Wesseling, Pieter
Westerman, Bart A
Widhalm, Georg
Woehrer, Adelheid
Yung, W K Alfred
Zadeh, Gelareh
Huse, Jason T
De Groot, John F
Stead, Lucy F
Verhaak, Roel G W
GLASS Consortium
R01 CA188228/CA/NCI NIH HHS/United States
P30 CA016672/CA/NCI NIH HHS/United States
R01 CA190121/CA/NCI NIH HHS/United States
UL1 TR001863/TR/NCATS NIH HHS/United States
CA170278/CA/NCI NIH HHS/United States
P30 CA034196/CA/NCI NIH HHS/United States
K99 CA226387/CA/NCI NIH HHS/United States
U54 CA193313/CA/NCI NIH HHS/United States
R01 CA215489/CA/NCI NIH HHS/United States
R00 CA226387/CA/NCI NIH HHS/United States
R01 CA219943/CA/NCI NIH HHS/United States
R01 CA108888/CA/NCI NIH HHS/United States
R01 NS094615/NS/NINDS NIH HHS/United States
R21 NS114873/NS/NINDS NIH HHS/United States
R01 CA179044/CA/NCI NIH HHS/United States
T32 GM008568/GM/NIGMS NIH HHS/United States
R01 CA230031/CA/NCI NIH HHS/United States
R01 CA218144/CA/NCI NIH HHS/United States
R01 CA222146/CA/NCI NIH HHS/United States
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
England
2019/11/22
Nature. 2019 Dec;576(7785):112-120. doi: 10.1038/s41586-019-1775-1. Epub 2019 Nov 20.},
   abstract = {The evolutionary processes that drive universal therapeutic resistance in adult patients with diffuse glioma remain unclear(1,2). Here we analysed temporally separated DNA-sequencing data and matched clinical annotation from 222 adult patients with glioma. By analysing mutations and copy numbers across the three major subtypes of diffuse glioma, we found that driver genes detected at the initial stage of disease were retained at recurrence, whereas there was little evidence of recurrence-specific gene alterations. Treatment with alkylating agents resulted in a hypermutator phenotype at different rates across the glioma subtypes, and hypermutation was not associated with differences in overall survival. Acquired aneuploidy was frequently detected in recurrent gliomas and was characterized by IDH mutation but without co-deletion of chromosome arms 1p/19q, and further converged with acquired alterations in the cell cycle and poor outcomes. The clonal architecture of each tumour remained similar over time, but the presence of subclonal selection was associated with decreased survival. Finally, there were no differences in the levels of immunoediting between initial and recurrent gliomas. Collectively, our results suggest that the strongest selective pressures occur during early glioma development and that current therapies shape this evolution in a largely stochastic manner.},
   keywords = {Adult
Chromosomes, Human, Pair 1
Chromosomes, Human, Pair 19
Disease Progression
Glioma/*genetics/pathology
Humans
Isocitrate Dehydrogenase/genetics
Mutation
Polymorphism, Single Nucleotide
Recurrence},
   ISSN = {0028-0836 (Print)
0028-0836},
   DOI = {10.1038/s41586-019-1775-1},
   year = {2019},
   type = {Journal Article}
}

Downloads: 1